---
document_datetime: 2025-12-01 14:25:11
document_pages: 29
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cerezyme-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: cerezyme-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 18.9167163
conversion_datetime: 2025-12-30 07:56:41.15392
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cerezyme

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0136              | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 16/10/2025                          |                                             | SmPC and PL                      |           |
| IA/0135              | A.7 - Administrative change - Deletion of manufacturing sites                                                     | 25/10/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0134/G          | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure   | 19/09/2024   | n/a        |                        |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------|
| N/0133             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                               | 16/05/2024   |            | PL                     |                                   |
| IB/0132            | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                               | 19/04/2024   | n/a        |                        |                                   |
| II/0131            | B.I.b.1.e - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a specification parameter which may have a significant effect on the overall quality of the AS and/or the FP                                                                                                                                                                   | 15/02/2024   | n/a        |                        |                                   |
| PSUSA/1727/ 202305 | Periodic Safety Update EU Single assessment - imiglucerase                                                                                                                                                                                                                                                                                                                                                     | 11/01/2024   | n/a        |                        | PRAC Recommendation - maintenance |
| IAIN/0129          | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                     | 03/04/2023   | 17/07/2023 | SmPC, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/1727/ 202205   | Periodic Safety Update EU Single assessment - imiglucerase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 12/01/2023   | n/a        |             |                         |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-------------------------|
| IB/0128              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 16/11/2022   | 17/07/2023 | SmPC and PL |                         |
| IA/0127/G            | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites                                                                                                                          | 31/08/2022   | 17/07/2023 | Annex II    | (excluding manufacturer |
| II/0123/G            | This was an application for a group of variations. B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.II.d.1.f - Change in the specification parameters and/or limits of the finished product - Deletion of a specification parameter which may have a significant effect on the overall quality of the finished product B.I.d.1.b.2 - Stability of AS - Change in the storage | 03/03/2022   | 29/06/2022 | Annex II    |                         |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| biological/immunological studies have not been performed a currently approved stability B.I.b.1.e - Change in the and/or limits of an AS, material/intermediate/reagent specification parameter effect on the overall quality B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.I.a.1.e - Change in the starting material/reagent/intermediate change relates to a biological material [-] used in the biological/immunological B.I.a.2.c - Changes in the the AS - The change refers manufacture of a biological/immunological which may have a significant product and is not related B.II.d.1.a - Change in the and/or limits of the finished specification limits B.I.b.1.c - Change in the and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method B.II.d.2.d - Change in test   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                    | (including replacement or addition) B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.c.1.b - Change in immediate packaging of the AS - Qualitative and/or quantitative composition for sterile and non-frozen biological/immunological ASs B.II.d.2.c - Change in test procedure for the finished product - Substantial change to or replacement of a biol/immunol/immunochemical test method or a method using a biol. reagent or replacement of a biol. reference preparation not covered by an   |            |            |          |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------|-----------------------------------|
| PSUSA/1727/ 202105 | Periodic Safety Update EU Single assessment - imiglucerase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 13/01/2022 | n/a        |          | PRAC Recommendation - maintenance |
| N/0125             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 05/11/2021 | 29/06/2022 | PL       |                                   |
| IA/0122/G          | This was an application for a group of variations. A.5.b - Administrative change - Change in the name                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 21/06/2021 | 29/06/2022 | Annex II |                                   |

<div style=\"page-break-after: always\"></div>

|         | finished product, including quality control sites (excluding manufacturer for batch release) A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure   |            |            |    | and/or address   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|------------------|
| IA/0121 | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                                                                                                                                                                                                                                                                                                                                                                           | 01/04/2021 | n/a        |    |                  |
| IA/0120 | B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter                                                                                                                                                                                                                                                                                                                                                                                                                     | 16/12/2020 | n/a        |    |                  |
| II/0118 | B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch control/testing takes place and any of the test method at the site is a biol/immunol method                                                                                                                                                                                                                                                                                                                        | 19/11/2020 | n/a        |    |                  |
| N/0119  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 29/10/2020 | 18/12/2020 | PL |                  |

<div style=\"page-break-after: always\"></div>

| IB/0117/G   | was an application for a group of variations. - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 18/02/2020   | 18/12/2020   | SmPC, Labelling and PL   | This B.II.d.2.a   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-------------------|
| IA/0116/G   | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites | 13/12/2019   | 18/12/2020   | Annex II and PL          |                   |
| II/0113/G   | This was an application for a group of variations. B.I.b.1.e - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a parameter which may have a significant                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 07/02/2019   | n/a          |                          | specification     |

<div style=\"page-break-after: always\"></div>

|                    | effect on the overall quality of the AS and/or the FP B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS         |            |            |                        |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/1727/ 201805 | Periodic Safety Update EU Single assessment - imiglucerase                                                                                                                                                                                                                                                     | 17/01/2019 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0115            | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                               | 15/01/2019 | n/a        |                        |                                   |
| IG/1003            | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                     | 20/12/2018 | 05/12/2019 | SmPC, Labelling and PL |                                   |
| IB/0112/G          | This was an application for a group of variations. B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol B.II.f.1.e - Stability of FP - Change to an approved stability protocol | 13/12/2018 | 05/12/2019 | SmPC, Labelling and PL |                                   |
| IB/0111/G          | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other                                                                                                                                                  | 12/11/2018 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|           | variation B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                                                                                                                                                                                                                                                                                       |            |            |    |     |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----|
| IB/0108/G | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                   | 14/05/2018 | n/a        |    |     |
| IA/0109   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                | 27/04/2018 | n/a        |    |     |
| N/0107    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                             | 07/03/2018 | 05/12/2019 | PL |     |
| WS/1262   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch control/testing takes place and any of the test method at the site is a biol/immunol method | 14/12/2017 | n/a        |    |     |
| II/0105   | Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch                                                                                                                                                                                                                                                            | 02/11/2017 | n/a        |    | N/A |

<div style=\"page-break-after: always\"></div>

|         | place for a biol/immunol product and any of the test methods at the site is a biol/immunol method B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place for a biol/immunol product and any of the test methods at the site is a biol/immunol method                     |            |            |    | control/testing takes   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-------------------------|
| N/0104  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                             | 10/08/2017 | 05/12/2019 | PL |                         |
| IB/0103 | B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB                                                                                                                                                                                                                                                      | 27/07/2017 | n/a        |    |                         |
| IB/0101 | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                                 | 20/04/2017 | n/a        |    |                         |
|         | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.d - Change in test procedure for AS or | 30/03/2017 | n/a        |    | II/0099/G               |

<div style=\"page-break-after: always\"></div>

|        | change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the   |            |            |    |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|
| N/0102 | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 22/02/2017 | 02/06/2017 | PL |

<div style=\"page-break-after: always\"></div>

| IB/0100/G   | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place   | 06/01/2017   | n/a        |                                  |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|
| IB/0098     | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                              | 27/10/2016   | n/a        |                                  |
| IA/0097     | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                                                                     | 20/09/2016   | n/a        |                                  |
| II/0094/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The change relates to a biological AS or a starting material [-] used in the manufacture of a biological/immunological product B.I.a.2.b - Changes in the manufacturing process of                                                                                                                                   | 14/07/2016   | 02/06/2017 | SmPC, Annex II, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|           | the AS - Substantial change to the manufacturing process of the AS which may have a significant impact on the quality, safety or efficacy of the medicinal product B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch control/testing takes place and any of the test method at the site is a biol/immunol method B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting   |            |     |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0096/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 10/05/2016 | n/a |

<div style=\"page-break-after: always\"></div>

|                    | changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                    |            |     |                                   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0095/G          | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 23/03/2016 | n/a |                                   |
| II/0093/G          | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.1.e - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a specification parameter which may have a significant effect on the overall quality of the AS and/or the FP              | 11/02/2016 | n/a |                                   |
| PSUSA/1727/ 201505 | Periodic Safety Update EU Single assessment - imiglucerase                                                                                                                                                                                                                                                                                                                                                               | 14/01/2016 | n/a | PRAC Recommendation - maintenance |
| IB/0091            | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                      | 28/10/2015 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0090   | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 10/04/2015   | n/a        |          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0089   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 19/12/2014   | n/a        |          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| II/0087   | Update of the RMP to reflect the results of the THEME survey, which tested the effectiveness of the educational materials for home infusion, evaluated as MEA 040.7, and to reflect the results of the 6th annual report on the pregnancy and lactation Registry in Gaucher patients, submitted in parallel to the variation as MEA 040.8. The Annex II of the Product Information was proposed to be brought in line with the latest version of the QRD template (9.0). The requested variation proposed amendments to Annex II and to the Risk Management Plan (RMP). C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required | 23/10/2014   | 28/10/2015 | Annex II | The MAH updated the RMP with data from the annual pregnancy report, including data from the pharmacovigilance database of the MAH and data from the Pregnancy Sub-registry. The data of the present annual report (1 June 2013 to 31 May 2014) is comparable to the previous reported year. No new safety issue has been identified. In addition, in line with the request made in the previous assessment report (MEA 040.7, CHMP conclusion adopted on 24 Jan 2014), the MAH proposes to use a questionnaire to follow-up each reported ADR as a routine pharmacovigilance activity to ensure that information is obtained on the setting in which the ADR occurred and risks associated with home infusion. The additional data submitted by the MAH are considered not to change the overall benefit/risk balance. The following point should be addressed by the MAH in the next update of the RMP: - The MAH should be aware that in Section III.3 of the RMP it is stated that the final study report of the Home Infusion Educational Material Effectiveness Tracking (THEME) Study is provided in Annex 9. However, this study report has been removed from the annex in this version of the RMP. In annex 9 of the RMP version 7.0 the pregnancy |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     | report (number 6) is provided.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------|
| IB/0086   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 17/10/2014 | n/a |                                  |
| IB/0088   | B.I.a.3.e - Change in batch size (including batch size ranges) of AS or intermediate - The scale for a biological/immunological AS is increased/decreased without process change (e.g. duplication of line)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 08/10/2014 | n/a |                                  |
| IB/0085/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 27/08/2014 | n/a |                                  |

<div style=\"page-break-after: always\"></div>

|         | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                           | 22/07/2014   | n/a   | IAIN/0084             |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------|
| IB/0083 | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                  | 11/07/2014   | n/a   |                       |
| IA/0081 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                         | 23/06/2014   | n/a   |                       |
| IB/0080 | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where takes place | 25/04/2014   | n/a   | batch control/testing |
| IB/0079 | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                           | 25/04/2014   | n/a   |                       |
| IG/0418 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                      | 11/04/2014   | n/a   |                       |
| IA/0077 | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                          | 11/12/2013   | n/a   |                       |

<div style=\"page-break-after: always\"></div>

| N/0076    | change in labelling or package leaflet not with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                   | 07/11/2013   | 28/10/2015   | PL   | Minor connected      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------|----------------------|
| IB/0075   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                         | 25/09/2013   | n/a          |      |                      |
| IB/0072/G | This was an application for a group of variations. B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the currently approved batch size B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line) B.II.b.3.z - Change in the manufacturing process of | 19/07/2013   | n/a          |      | the finished product |
| IB/0074   | B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                        | 21/06/2013   | n/a          |      |                      |
| IB/0073   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                   | 13/06/2013   | n/a          |      |                      |
| IA/0071   | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect information                                                                                                                                                                                                                                                                                                                                 | 21/05/2013   | n/a          |      | the product          |

<div style=\"page-break-after: always\"></div>

| IA/0069/G   | was an application for a group of variations. - Submission of a new or updated Ph. TSE Certificate of suitability - Updated certificate an already approved manufacturer - Submission of a new or updated Ph. TSE Certificate of suitability - Updated certificate an already approved manufacturer new or updated Ph.   | 10/04/2013   | n/a   | This B.III.1.b.3 Eur. from B.III.1.b.3 Eur. from B.III.1.b.3 - Submission of a Eur. TSE Certificate of suitability from an already approved manufacturer B.III.1.b.3 - Submission of a Eur. TSE Certificate of suitability from an already approved manufacturer B.III.1.b.3 - Submission of a Eur. TSE Certificate of suitability from an already approved manufacturer B.I.a.4.c - Change to in-process   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0283     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                           | 22/03/2013   | n/a   |                                                                                                                                                                                                                                                                                                                                                                                                             |
| IB/0068/G   | This was an application for a group of variations. B.I.a.4.f - Change to in-process tests or limits applied during the manufacture of the AS - Addition or replacement of an in-process test as a result of a safety or quality issue B.I.b.1.c - Change in the specification parameters                                 | 20/03/2013   | n/a   | and/or limits of an AS, starting                                                                                                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Addition of a new parameter to the specification with its test method                                                                                                                                                                                                                                                |            |            |    | specification corresponding   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-------------------------------|
| IB/0067   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                         | 07/12/2012 | n/a        |    |                               |
| N/0066    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                     | 19/07/2012 | 28/10/2015 | PL |                               |
| N/0065    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                     | 13/04/2012 | 28/10/2015 | PL |                               |
| IG/0119/G | This was an application for a group of variations. B.III.1.b.3 - Submission of a new or updated Ph. Eur. TSE Certificate of suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new or updated Ph. Eur. TSE Certificate of suitability - Updated certificate from an already approved manufacturer | 07/11/2011 | n/a        |    |                               |
| IG/0104   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                        | 27/09/2011 | n/a        |    |                               |
| IG/0103/G | This was an application for a group of variations. B.III.1.b.3 - Submission of a new or updated Ph. Eur. TSE Certificate of suitability - Updated certificate                                                                                                                                                                                        | 21/09/2011 | n/a        |    |                               |

<div style=\"page-break-after: always\"></div>

|         | from an already approved manufacturer B.III.1.b.3 - Submission of a new or updated Ph. Eur. TSE Certificate of suitability - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                     |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0062 | B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 27/05/2011 | n/a        | Annex II and PL                  |                                                                                                                                                                                                                                                                                                                                                                     |
| N/0061  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 10/05/2011 | n/a        | PL                               |                                                                                                                                                                                                                                                                                                                                                                     |
| II/0057 | C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                     | 23/09/2010 | 25/10/2010 | SmPC and PL                      |                                                                                                                                                                                                                                                                                                                                                                     |
| II/0058 | Update of section 4.2 of the SmPC with a statement on the possibility of home infusion for a selected population of patients. Consequently, Section 3 of the Package Leaflet was updated with a statement on the possibility of home infusion. Additionally, several minor adjustments have been implemented to bring the SmPC, labelling and package leaflet in line with the current revised QRD template. Annex II was affected. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data | 22/07/2010 | 26/08/2010 | SmPC, Annex II, Labelling and PL | Based on the assessment of the submitted Healthcare Professional guidance and the patient manual and on the evaluation of identified and potential risks of home infusion, the CHMP accepted the proposal for the MAH to include the possibility of home infusion in the PI. Section 4.2 of the SmPC and section 3 of the Package Leaflet were updated accordingly. |

<div style=\"page-break-after: always\"></div>

| II/0055   | Changes in the manufacturing process if the active substance B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal                                  | 22/07/2010   | 30/07/2010   |             |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------|
| IB/0059   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                               | 30/06/2010   | n/a          |             |
| IB/0056   | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with NO new additional data are submitted by the MAH | 19/06/2010   | n/a          | SmPC and PL |
| IA/0060   | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                 | 18/06/2010   | n/a          |             |
| IA/0054   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS                                                                      | 12/03/2010   | n/a          |             |
| II/0049   | Change to the test methods for the active sustance. Change(s) to the test method(s) and/or                                                                                                                                                                 | 19/11/2009   | 25/11/2009   |             |

<div style=\"page-break-after: always\"></div>

|         | specifications for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0053 | IA_31_a_Change to in-process tests/limits during manufacture - tightening of in-process limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 24/11/2009 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| II/0050 | Addition of the active substance manufacturing site. Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 24/09/2009 | 29/09/2009 |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IA/0048 | IA_16_b_Submission of new TSE certificate relating to active substance - other substances                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 15/07/2009 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| II/0046 | Update of sections 4.2 \"Posology and method of administration\", 4.4 \"Special warnings and precautions for use\", 4.9 \"Overdose\", 5.1 \"Pharmacodynamic properties\" of the Summary of Product Characteristics (SPC) to reflect the current knowledge on Gaucher disease and Cerezyme's efficacy mainly based on comprehensive literature review in order to ensure optimal treatment guidance. The MAH also took the opportunity to update section 2 \"Qualitative and quantitative composition\" and to include in section 4.8 \"Undesirable effects\" the adverse event 'backache'. The Package Leaflet (PL) was updated accordingly. Update of Summary of Product Characteristics and Package Leaflet | 29/05/2009 | 30/06/2009 | SmPC and PL | Data available mainly from the literature confirm the positive effect of Cerezyme on the haematological, visceral and skeletal signs and symptoms of Gaucher disease in both type 1 and type 3 patients. Dose-response analyses have shown that response to Cerezyme is dose-dependent. Current knowledge as described in literature also allowed a more comprehensive and up-to-date description of Gaucher disease and its clinical manifestations. Pulmonary hypertension is recognised as an uncommon complication in patients with Gaucher disease and is unlikely related to Cerezyme therapy based on current knowledge; pulmonary hypertension is therefore moved from section 4.4 to section 5.1. Literature analysed refers only to treatment schedules with infusions every other week. Due to the demonstration of the effectiveness and safety of this two-week schedule, the 3 times per week regimen has become obsolete and therefore was removed from the SPC. Results from two clinical studies showed that maintenance treatment with 4 weeks intervals could be a therapeutic option for some |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                    |            |            |             | adult patients with stable residual Gaucher disease type 1, but clinical data are limited. Recommendation for the infusion administration has been made more informative in section 4.2 of the SPC by providing a recommendation for infusion rate only, removing the duration of infusion which is not taking into account the fact that the dose is individualised. Based on a cumulative review of the MAH safety database from May 1994 to May 2008 backache was added in section 4.8 as an uncommon adverse event. This search identified 54 adverse events (AEs) reported in 46 patients. Of these 54 AEs, 52 were considered to be related to treatment and 36 occurred within 24 hours of infusion.   |
|---------|----------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0047 | IB_31_a_Change to in-process tests/limits during manufacture - tightening of in-process limits     | 07/05/2009 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| II/0045 | Update of Summary of Product Characteristics and Package Leaflet                                   | 20/11/2008 | 22/12/2008 | SmPC and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| II/0042 | Change(s) to the manufacturing process for the finished product                                    | 30/05/2008 | 05/06/2008 |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IB/0044 | IB_38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient | 25/04/2008 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IB/0043 | IB_13_b_Change in test proc. for active substance - other changes (replacement/addition)           | 25/04/2008 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| II/0040 | Change(s) to the manufacturing process for the finished product                                    | 20/09/2007 | 25/09/2007 |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

| R/0039   | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                          | 19/07/2007   | 17/09/2007   | SmPC, Annex II, Labelling and PL   | Based on the review of the available information the CHMP is of the opinion that the quality, the safety and the efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considers that the benefit/risk profile of Cerezyme continues to be favourable.                                                                                                    |
|----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0041  | IB_33_Minor change in the manufacture of the finished product                                                                                                                                                                                                                                                                                                                                                                    | 13/06/2007   | n/a          |                                    |                                                                                                                                                                                                                                                                                                                                                                                                               |
| II/0037  | Update of section 4.8 of the SPC to include \"arthralgia\" and \"paraesthesia\" as adverse reactions, as requested by the CHMP following assessment of PSUR 9 (covering the period from 1 June 2004 to 31 May 2006). Section 4 of the PL has been updated accordingly. Section 6 of the PL was updated with the local representatives in Bulgaria, Romania and Hungary was updated. Update of Summary of Product Characteristics and | 22/02/2007   | 04/04/2007   | SmPC and PL                        | Since the approval of Cerezyme in the US in May 1994 until November 2006, a total of 52 case reports of arthralgia and 15 case reports of paraesthesia were received. Paraesthesia was sometimes suggestive of hypersensitivity and responded to treatment with antihistamines and/or corticosteroids. These uncommon adverse events have been included in section 4.8 of the SPC and in section 4 of the PL. |
| II/0038  | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                  | 22/02/2007   | 01/03/2007   |                                    |                                                                                                                                                                                                                                                                                                                                                                                                               |
| II/0036  | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                  | 27/07/2006   | 07/08/2006   |                                    |                                                                                                                                                                                                                                                                                                                                                                                                               |
| IB/0035  | IB_17_b_Change in the storage conditions for the active substance                                                                                                                                                                                                                                                                                                                                                                | 11/04/2006   | n/a          |                                    |                                                                                                                                                                                                                                                                                                                                                                                                               |
| N/0034   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                 | 21/12/2005   | n/a          | PL                                 |                                                                                                                                                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

| II/0033   | Change(s) to the manufacturing process for the finished product                                             | 17/11/2005   | 22/11/2005   |             |                                                                                                                                                                                                                                                                          |
|-----------|-------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0032   | Update of or change(s) to the pharmaceutical documentation                                                  | 15/09/2005   | 29/09/2005   |             |                                                                                                                                                                                                                                                                          |
| II/0031   | Change(s) to the manufacturing process for the active substance                                             | 15/09/2005   | 29/09/2005   |             |                                                                                                                                                                                                                                                                          |
| II/0029   | Update of Summary of Product Characteristics and Package Leaflet                                            | 17/02/2005   | 11/04/2005   | SmPC and PL | To change section 4.4 (Special warnings and special precautions for use) of the Summary of Product Characteristics (SPC) as requested by CHMP and to include a change in the contact details of the French and Polish local representatives in the Package Leaflet (PL). |
| IB/0030   | IB_38_c_Change in test procedure of finished product - other changes                                        | 03/03/2005   | n/a          |             |                                                                                                                                                                                                                                                                          |
| II/0028   | The Marketing Authorisation Holder Applied to amend the manufacturing process for Cerezyme. Quality changes | 17/02/2005   | 22/02/2005   |             |                                                                                                                                                                                                                                                                          |
| II/0027   | Quality changes                                                                                             | 21/10/2004   | 25/10/2004   |             |                                                                                                                                                                                                                                                                          |
| IB/0024   | IB_17_b_Change in the storage conditions for the active substance                                           | 14/06/2004   | n/a          |             |                                                                                                                                                                                                                                                                          |
| II/0023   | Change(s) to the manufacturing process for the finished product                                             | 03/06/2004   | 11/06/2004   |             |                                                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|         | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure   | 26/05/2004   | n/a        |                                  | IA/0026   |
|---------|--------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------|
| N/0025  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 01/05/2004   | n/a        | PL                               |           |
| IA/0022 | IA_16_b_Submission of new TSE certificate relating to active substance - other substances        | 30/03/2004   | n/a        |                                  |           |
| II/0018 | Extension of indication to include type 3 Gaucher's disease Extension of Indication              | 22/05/2003   | 28/08/2003 | SmPC, Annex II and PL            |           |
| I/0020  | 12_Minor change of manufacturing process of the active substance                                 | 24/07/2003   | n/a        |                                  |           |
| I/0019  | 24_Change in test procedure of active substance                                                  | 24/07/2003   | n/a        |                                  |           |
| I/0021  | 11b_Change in supplier of an intermediate compound used in manufacture of the active substance   | 03/07/2003   | 17/07/2003 |                                  |           |
| R/0017  | Renewal of the marketing authorisation.                                                          | 19/09/2002   | 11/12/2002 | SmPC, Annex II, Labelling and PL |           |
| I/0015  | 12_Minor change of manufacturing process of the active substance                                 | 21/03/2002   | 11/04/2002 |                                  |           |
| I/0016  | 03_Change in the name and/or address of the marketing authorisation holder                       | 07/12/2001   | 26/03/2002 | SmPC, Labelling and              |           |

<div style=\"page-break-after: always\"></div>

|         |                                                                  |            |            | PL                               |
|---------|------------------------------------------------------------------|------------|------------|----------------------------------|
| I/0013  | 12_Minor change of manufacturing process of the active substance | 01/03/2001 | 06/04/2001 |                                  |
| I/0014  | 26_Changes to comply with supplements to pharmacopoeias          | 08/02/2001 | n/a        |                                  |
| X/0010  | X-3-iii_Addition of new strength                                 | 23/09/1999 | 28/01/2000 | SmPC, Annex II, Labelling and PL |
| II/0011 | Update of Summary of Product Characteristics and Package Leaflet | 28/07/1999 | 16/11/1999 | SmPC, Labelling and PL           |
| I/0009  | 12_Minor change of manufacturing process of the active substance | 23/09/1999 | n/a        |                                  |
| II/0008 | Update of Summary of Product Characteristics and Package Leaflet | 28/01/1999 | 18/06/1999 | SmPC, Labelling and PL           |
| I/0007  | 15_Minor changes in manufacture of the medicinal product         | 23/07/1998 | n/a        |                                  |
| I/0004  | 12_Minor change of manufacturing process of the active substance | 25/06/1998 | n/a        |                                  |
| I/0005  | 12_Minor change of manufacturing process of the active substance | 25/03/1998 | n/a        |                                  |
| I/0003  | 12_Minor change of manufacturing process of the active substance | 25/03/1998 | n/a        |                                  |

<div style=\"page-break-after: always\"></div>

| I/0002   | 02_Change in the name of the medicinal product (either invented name of common name) 15_Minor changes in manufacture of the medicinal product   | 25/03/1998   | n/a        |    |
|----------|-------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|
| I/0001   | 16_Change in the batch size of finished product                                                                                                 | 25/03/1998   | n/a        |    |
| N/0006   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                | 09/03/1998   | 15/08/1998 | PL |